[ Price : $8.95]
FDA approves a SpringWorks Therapeutics NDA for Gomekli (mirdametinib) for treating certain patients with neurofibromatosis Type 1...[ Price : $8.95]
FDA accepts for review a Regeneron Pharmaceuticals BLA resubmission for linvoseltamab for treating adult patients with relapsed/re...[ Price : $8.95]
Former FDA commissioner Scott Gottlieb says the agency should revert to clinical decision support system regulatory policies appro...[ Price : $8.95]
FDA says Jeremy Brown of Simi Valley, CA has been sentenced for introducing unapproved drugs into interstate commerce.[ Price : $8.95]
Sentec/Percussionaire recalls its Phasitron breathing circuit kits after receiving a complaint that the venturi component of the k...[ Price : $8.95]
Pliant Therapeutics pauses enrollment and dosing due to an undisclosed safety concern in its ongoing BEACON-IPF Phase 2b trial of ...[ Price : $8.95]
FDA posts a final guidance entitled Institutional Review Board (IRB) Written Procedures that is intended to harmonize FDA and HHS ...[ Price : $8.95]
Boehringer Ingelheim plans to submit an NDA for nerandomilast for treating progressive pulmonary fibrosis following its release of...